ACTINIC KERATOSIS - SCORE
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - South Carolina policy alerts
Know when Blue Cross Blue Shield - South Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs step-therapy coverage for diclofenac sodium gel 3% used for actinic keratosis under the South Carolina Bronze 6T formulary. Coverage requires a trial of topical fluorouracil or topical imiquimod.
No material clinical or coverage changes in this revision.
Coverage Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.